| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.1 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.079 | 0.2 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.2 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.2 |